1 |
Sarcomas revisitedTaylor, Deryck Arnold 06 April 2017 (has links)
No description available.
|
2 |
Oral HIV-associated Kaposi sarcoma: A clinical study from theGa-Rankuwa area, South AfricaKhammisa, Razia Abdool Gafaar January 2011 (has links)
Thesis (M Med (Periodontics and Oral Medicine))--University of Limpopo, 2011. / Background: Kaposi sarcoma (KS) is the most common neoplasm diagnosed in HIV-seropositive subjects. HIV-associated KS (HIV-KS) may affect any body system and the disease may be slowly progressing or fulminant. Oral involvement is frequent and extensive oral HIV-KS is associated with poor prognosis.
Methods: All cases of oral HIV-KS treated in the Department of Periodontology and Oral Medicine over a period of seven years were included in this retrospective study. A record was made regarding the clinical and laboratory features, and differences in these features between males and females were statistically tested. The differences between the percentages of the different clinical appearances of oral HIV-KS lesions; and between the features of oral HIV-KS in patients who contracted HIV infection before the diagnosis of oral KS and those who were diagnosed with HIV infection at the time of oral KS presentation were also tested.
Results: Of the 37 patients included in the study, 54% were females and 46% were males and two patients (5%) were children. In 21 patients (57%) the initial presentation of HIV-KS was in the mouth. Seventeen patients (46%) were diagnosed with HIV infection and oral KS at the same time. At the time of oral HIV-KS diagnosis, 29 patients (78%) had multiple lesions affecting one or several sites.
There were no statistically significant differences between males and females regarding the clinical and laboratory features of oral HIV-KS except for the size of the lesions. The percentage of lesions <10mm was significantly lower in females than males (chi-squared test: p=0.007), whereas the percentage of lesions ≥10mm≤50mm was significantly higher in females than in males (chi-squared test: p=0.0004). There were significantly more patients with multiple oral HIV-KS lesions than patients with single oral HIV-KS lesions (binomial distribution test: p=0.0003). At the time of oral HIV-KS diagnosis, the difference between
ix
the average CD4+ T cell counts of the patients who were concurrently diagnosed with HIV infection and oral KS (130cells/mm3), and those who contracted HIV infection before developing oral HIV-KS (90 cells/mm3) was not statistically different.
Nine patients (24%) developed facial lymphoedema in association with multifocal exophytic oral HIV-KS lesions. The average CD4+ T cell counts of these patients at the time of oral HIV-KS diagnosis was 28 cells/mm3, and was statistically significantly lower (t-test: p= 0.01) than the average CD4+ T cell count (133 cells/mm3) of those who did not develop facial lymphoedema. All the patients with facial lymphoedema died, on average within two weeks from the occurrence of facial lymphoedema. One patient (2.7%) developed immune reconstitution inflammatory syndrome (IRIS) – associated oral HIV-KS, and his oral HIV-KS resolved following administration of highly active antiretroviral therapy (HAART) and systemic cytotoxic chemotherapy, and surgical excision.
Out of the 28 patients who were not lost to follow-up, 21 (75%) died, on average within 13.6 weeks from the time of oral HIV-KS diagnosis and seven (25%) survived. At the time of oral HIV-KS diagnosis the difference in the average CD4+ T cell count of the patients who died (64 cells/mm3) and those who survived (166 cells cells/mm3) was statistically significant (t-test: p=0.016). The prognosis of the patients who received cytotoxic chemotherapy was better than the prognosis of those who received only HAART, or those who were HAART-naïve.
Conclusions: Oral HIV-KS affects females more frequently than males (M:F = 1:1.2), and it is not uncommon in children. A lower CD4+ T cell count at the time of oral HIV-KS diagnosis is associated with a poor prognosis. Patients who develop facial lymphoedema during the course of HIV-KS disease, die soon thereafter. Oral HIV-KS can be successfully treated with systemic cytotoxic chemotherapy.
|
3 |
Die Strahlensensibilität von synchronisierten Yoshida-SarkomzellenHeitz, Jörg, January 1979 (has links)
Thesis (doctoral)--Freie Universität Berlin, 1979.
|
4 |
Soft tissue sarcomas: long-term aspects of combined modality treatmentThijssens, Katja Maria Jozef. January 2006 (has links)
Proefschrift Rijksuniversiteit Groningen. / Met lit.opg. - Met samenvatting in het Nederlands.
|
5 |
Synovial sarcoma : a Scandinavian Sarcoma Group project /Skytting, Björn, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 6 uppsatser.
|
6 |
Sarcomas of the jaws thesis submitted in partial fulfillment ... oral pathology /Rattner, Moses. January 1939 (has links)
Thesis (M.S.)--University of Michigan, 1939.
|
7 |
Genetic and serologic characterization of human herpesvirus type 8 (HHV -8) IN South Africa.Alagiozoglou, Pandeli (Lee) 06 March 2014 (has links)
Human herpes virus type 8 (HHV-8) is strongly implicated as the etiological agent of
Kaposi’s sarcoma (KS). The incidence of KS in South Africa is increasing in parallel with the HIV-1 epidemic. Molecular and serological prevalence of HHV-8 in HIV-1 infected individuals with and without KS was investigated. DNA fragments from ORF26 (capsid, 330BAM233) and ORF75 (tegument) regions were used to determine the prevalence of HHV-8 DNA in peripheral blood mononuclear cells (PBMC) from 429 HIV-1 infected individuals, 95 of whom had histologically confirmed KS. Of those without KS, 14 (4.2%) were PGR positive for HHV-8 DNA. In the individuals with KS, the proportion of HHV-8 DNA positive PBMC samples was 11 times higher (46/95,48%). Similarly, an immunofluorescence assay showed that 78% of KS patients had antibodies to HHV-8 compared to 16% of KS negative individuals. Among the KS group, 93% of PCRpositive samples were also HHV-8 antibody positive compared to only 66% of PCR negative samples indicating that viremia is associated with good antibody responses. Matched lymph node and PBMC samples were available for 8 patients. HHV-8 DNA was more
frequently detected in the lymph node (3/8) than in the blood (1/8), suggesting that the lymph nodes are a reser / o r for HHV-8. These data confirm the association between HHV-8 and KS and suggest that there is a high background prevalence of HHV-8 infection in HIV-1 infected individuals in South Africa.
The ORP 75 gene of 40 HHV-8 strains was sequenced and the phylogenetic relationships
between South African and already published sequences were investigated. The majority (n=29) of strains overlapped with the published A and B subgroups and were termed A/B variants.Three strains were classified as subgroup C while 8 sequences did not cluster with any of the previously classified subgroups and were termed novel (N) group. The DNA distance of this novel group differed from the A, B and C subgroups by 4.7%, 3.8% and 4,5% respectively although within the N group there was only 0.4% variation. The addition of this group significantly increased the number of subgroup-specific polymorphisms from 17 to 47 over a 804 bp region. There was sufficient inter-subgroup genetic diversity that single strand conformational polymorphisms (SSCP) could be used to rapidly identify them. Thus, based on the analysis of the ORF75 gene, a unique HHV-8 sub-group is present in South Africa which accounts for 20% of circulating strains. Further studies are required to determine the extent of evolutionary phytogeny, distribution and pathogenic potential of this novel group.
|
8 |
Candida infection in oral lesions of kaposi sarcomaSibda, Arshaad 11 November 2011 (has links)
Background
Oral candidiasis is the most common infection of the oral mucosa of HIV-seropositive
patients, although its frequency is rapidly decreasing with the advent of highly active
antiretroviral therapy (HAART). Many questions regarding its complex pathogenesis remain
unanswered. The diagnosis is usually established with non-invasive techniques such as
mucosal smears. Oral lesions of HIV-associated Kaposi sarcoma (HIV-KS) are routinely
biopsied and frequently show secondary infection with Candida albicans or other Candida
species.
Aims and objectives
The aim of this investigation was to determine the frequency and histomorphology of
secondary Candidal infection of the surface epithelium of oral HIV-associated KS lesions
(HIV-KS), which are routinely biopsied in HIV infected patients.
Materials and methods
Haematoxylin and eosin (HE), and Periodic Acid-Schiff (PAS) stains of 133 cases of oral
Kaposi sarcoma diagnosed between the period 2003 and 2007 within the Division of Oral
Pathology were examined histologically for intensity and morphology of Candidal
colonisation, depth of invasion, number of organisms, epithelial reactions and associated
inflammatory response. The depth of Candidal invasion and severity of infection were
correlated with the available CD4 T cell counts of HIV seropositive patients at the time of
biopsy. Results
Almost forty one percent (40.62%) of all oral HIV-KS cases were secondarily infected with
Candida species. The intensity varied from an isolated single pseudohyphus to matted
colonies of vegetative yeasts and psuedohyphae. Whilst in most cases the organisms did not
invade beyond the parakeratin layer, pseudohyphae were noted extending into the stratum
spinosum in 2 cases, and a single case showed a pseudohyphus within the lamina propria. A
further 2 cases showed pseudohyphae growing in the pyogenic membrane. Neutrophilic
permeation of the epithelium and Munro micro-abscess formation, features commonly
associated with Candidal infection, were frequently present even in the absence of Candidal
infection. Candidal organisms were often present in the absence of inflammation.
Conclusion
Oral lesions of HIV-KS are commonly secondarily infected with large numbers of Candidal
organisms. The morphological characteristics of secondary Candidal infection within the
surface epithelium of HIV-KS lesions suggest an altered pathogenetic pathway. Further
studies are necessary in this regard.
|
9 |
Epidemiologic study of risk factors for Ewing's sarcoma family of tumors in Australia /Valery, Patricia Casarolli. January 2002 (has links) (PDF)
Thesis (Ph. D.)--University of Queensland, 2002. / Includes bibliographical references.
|
10 |
Beiträge zur Differentialdiagnose zwischen den gliösen und sarkomatösen Geschwülsten des Gehirns ... /Treutlein, Adolf. January 1898 (has links)
Inaugural dissertation.--K. bayer. Julius-Maximilians-Universität Würzburg.
|
Page generated in 0.0522 seconds